Tudor Investment Corp
CRNX icon

Tudor Investment Corp’s Crinetics Pharmaceuticals CRNX Stock Holding History

Tudor Investment Corp’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Buy
+46,021
New +$2.06M ﹤0.01% 1984
2024
Q1 		– Sell
-39,764
Closed -$1.41M – 2311
2023
Q4 		$1.41M Buy
39,764
+6,764
+20% +$207K 0.01% 1278
2023
Q3 		$981K Buy
33,000
+5,972
+22% +$123K 0.01% 1308
2023
Q2 		$487K Buy
+27,028
New +$539K 0.01% 1726
2022
Q4 		– Sell
-26,753
Closed -$525K – 2466
2022
Q3 		$525K Buy
+26,753
New +$546K 0.01% 1364

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Tudor Investment Corp's CRNX Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Crinetics Pharmaceuticals (CRNX) in Q1 2026: 46,021 shares worth $1.67M. The stake represents ﹤0.01% of the portfolio and ranks #1984 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in CRNX as recently as Q4 2023.

Tudor Investment Corp first reported a position in CRNX in Q3 2022 and has held it in 5 quarters since. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

  • Tudor Investment Corp held 46,021 shares of Crinetics Pharmaceuticals worth $1.67M as of Q1 2026.
  • Crinetics Pharmaceuticals was a new Tudor Investment Corp position in Q1 2026.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1984 holding.
  • Tudor Investment Corp first reported a position in Crinetics Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • 243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.